Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America

Hepatology

Volumn 27, Issue 6, 1998, Pages 1661-1669

  Bonkovsky, Herbert L ^a,b   Poh Fitzpatrick, Maureen ^c   Pimstone, Neville ^d,e   Obando, Jorge ^a,b   Di Bisceglie, Adrian ^f   Tattrie, Christine ^a   Tortorelli, Kristina ^a,b   Leclair, Paula ^a,b   Mercurio, Mary G ^c   Lambrecht, Richard W ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; COPROPORPHYRIN; ESTROGEN; HLA ANTIGEN; ILLICIT DRUG; PORPHYRIN; UROPORPHYRIN;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN THERAPY; FEMALE; GENE MUTATION; HEMOCHROMATOSIS; HEPATITIS C; HLA SYSTEM; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; PORPHYRIA CUTANEA TARDA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; URINE LEVEL;

ADULT; AGED; FEMALE; HEPACIVIRUS; HEPATITIS C; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; NORTH AMERICA; PORPHYRIA CUTANEA TARDA;

EID: 17344362638     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270627     Document Type: Article

References (28)

1. Bonkovsky HL. Porphyrin and heme metabolism and the porphyrias. In: Zakim D, Boyer TD, eds. Hepatology, A Textbook of Liver Disease, 2nd ed. Philadelphia: Saunders, 1990:378-424.
2. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The Porphyrias. In: Scriver CR, Beaude AL, Sly WS, Valle D, eds. The Molecular and Metabolic Basis of Inherited Disease. 7th ed. McGraw-Hill, New York, 1995:2103-2160.
3. Elder GH. Porphyria cutanea tarda. Semin Liver Dis 1998;18:67-75.
4. Herrero C, Vincente A, Bruguera M, Ercilla MG, Barrera JM, Vidai J, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993;341:788-789.
5. Lacour JP, Bodokh I, Castanet J, Bekri S, Ortonne JP. Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 1993;128:121-123.
6. Fargion S, Piperno A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. HEPATOLOGY 1992;16:1322-1326.
7. Murphy A, Dooley S, Hillary IB, Murphy GM. HCV infection in porphyria cutanea tarda. Lancet 1993;341:1534-1535.
8. Stolzel U, Kostler E, Koszka C, Stoffler-Meilicke M, Schuppan D, Domasundaram R, et al. Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. HEPATOLOGY 1995;21:1500-1503.
9. Malina L, Arenberger P, Keacikova J. Frekvence virove hepatitidy C u nemocnych pozdni kozni porfyrii (PCT). Cas Lek Cesk 1994;133:599-601.
10. Siersema PD, ten Kate FJW, Mulder PGH, Wilson JHP. Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence. Liver 1992;12:56-61.
11. Gibson PR, Ratnaike S, Blake D, Sinickas V Porphyria cutanea tarda and hepatitis C. Med J Aust 1995;162:54.
12. Salmon P, Oakley A, Rademaker M, Duffull M. Hepatitis C virus infection and porphyria cutanea tarda in Australia/Asia. Arch Dermatol 1996;132:91.
13. Koester G, Feldman J, Bigler C. Hepatitis C in patients with porphyria cutanea tarda. J Am Acad Dermatol 1994;31:1054.
14. Lim HW, Harris HR, Fotiades J. Hepatitis C virus infection in patients with porphyria cutanea tarda evaluated in New York, NY. Arch Dermatol 1995;131:849.
15. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997;349:321-323.
16. Santos M, Clevers HC, Marx JM, Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda. N Engl J Med 1997;336:1327-1328.
17. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class-I like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996;13:399-408.
18. Bonkovsky HL. Mechanism of iron potentiation of hepatic uroporphyria: studies in cultured chick embryo liver cells. HEPATOLOGY 1989;10:354-364.
19. Mukerji SK, Pimstone NR, Burns M. Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity for ferrous iron: its potential role in the genesis of porphyria cutanea tarda. Gastroenterology 1984;87:1248-1254.
20. Siersema PD, Radenmakers LHPM, Cleton MI, ten Kate FJ, de Bruijn WC, Marx JJ, Wilson JH. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda - the role of iron. J Hepatol 1995;23:259-267.
21. Rubin RB, Barton AL, Banner BF, Bonkovsky HL. Iron and chronic viral hepatitis: emerging evidence for an important interaction. Dig Dis 1995;13:223-238.
22. Bonkovsky HL, Banner BF- Lambrecht RW, Rubin RB. Iron in liver diseases other than hemochromatosis. Semin Liver Dis 1996;16:65-82.
23. Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral hepatitis. HEPATOLOGY 1997;25:759-768.
24. H. Bonkovsky, M.Poh-Fitzpatrick, C. Tattrie, A. DiBisceglie, and the U.S. HCV/PCT Study Group. Porphyria cutanea tarda and hepatitis C in the USA. HEPATOLOGY 1996;24:486A.
25. Bonkovsky HL, Healey JF, Lourie AN, Gerron GG. Intravenous hemealbumin in acute intermittent porphyria. Evidence for repletion of hepatic hemoproteins and regulatory heme pools. Am J Gastroenterol 1991;86:1050-1056.
26. Tong MJ, Reddy KR, Lee WM, Pockros PJ, Hoefs JC, Keeffe EB, et al. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. HEPATOLOGY 1997;26:747-754.
27. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993;74:1093-1102.
28. Mukerji SK, Pimstone NR. Reduced substrate affinity for erythrocyte uroporphyrinogen decarboxylase constitutes the inherent biochemical defect in porphyria cutanea tarda. Biochem Biophys Res Commun 1985;127:517-525.